HCA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03
Fiyat $426.69
Piyasa Değeri (MRQ) $93.00B
P/E (TTM) 14.3
Hisse Başına Kâr (TTM) $29.82
Gelir (TTM) $78.01B
Temettü Verimi 0.71%
ROE (TTM) -124.0%
D/E Borç/Özsermaye (MRQ) -6.5
52 Haftlık Aralık $354–$557

HCA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04
aralık
çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

HCA Healthcare, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗

Wikidata ↗

sektörHealth Care endüstriHealth Care çalışanlar230.000 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06
Gelir$75.60B
2016-12-31 → 2025-12-31
Hisse Başına Kâr$28.33
2016-12-31 → 2025-12-31
Serbest Nakit Akışı$7.69B
2016-12-31 → 2025-12-31
Net kar marjı8.8%
2018-12-31 → 2025-12-31
Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik 5 Yıllık trend HCA 5Y ort. Akran Ortalaması Sonuç
P/E (TTM) 14.35Y ort. ≈13.8 ≈13.8 16.5 Düşük değerli
F/S (TTM) 1.25Y ort. ≈1.2 ≈1.2 1.2 Adil değer
F/D (MRQ) -14.05Y ort. ≈-39.2 ≈-39.2 · ·
EV / EBITDA 38.75Y ort. ≈37.3 ≈37.3 18.9 Aşırı değerli
Fiyat / Serbest Nakit Akışı (TTM) 15.55Y ort. ≈14.6 ≈14.6 · ·
Fiyat / Nakit Akışı (TTM) 8.45Y ort. ≈7.9 ≈7.9 9.1 Düşük değerli
EV / Revenue (EV / Gelir) 1.85Y ort. ≈1.8 ≈1.8 · ·
EV / FCF 17.75Y ort. ≈21.8 ≈21.8 · ·
PEG Ratio (PEG Oranı) ≈0.7 · · ·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

13
Temettü Verimi0.71%
Temettü Ödeme Oranı10.0%
Yıllıklaştırılmış Ödeme≈$3.12Üç Aylık Ödeme
5 Yıllık Temettü CAGR≈21.9%Hisse başına, bölünmeye göre ayarlanmış
Büyüme Serisi≈5Ardışık temettü büyüme yılları
Ex-tarihiMiktarPara BirimiTemettü Verimi
Eyl 16, 2026$0,78USD≈0.71%
Haz 16, 2026$0,78USD≈0.76%
Mar 17, 2026$0,78USD≈0.58%
Ara 15, 2025$0,72USD≈0.60%
Eyl 16, 2025$0,72USD≈0.71%
Haz 16, 2025$0,72USD≈0.75%
Mar 17, 2025$0,72USD≈0.82%
Ara 13, 2024$0,66USD≈0.84%
Eyl 16, 2024$0,66USD≈0.64%
Haz 14, 2024$0,66USD≈0.75%
Mar 14, 2024$0,66USD≈0.76%
Ara 13, 2023$0,60USD≈0.89%
Eyl 14, 2023$0,60USD≈0.90%
Haz 15, 2023$0,60USD≈0.81%
Mar 16, 2023$0,60USD≈0.90%
Ara 13, 2022$0,56USD≈0.92%
Eyl 15, 2022$0,56USD≈1.0%
Haz 15, 2022$0,56USD≈1.1%
Mar 16, 2022$0,56USD≈0.75%
Ara 13, 2021$0,48USD≈0.90%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14
Ort. Sürpriz 7.9%
Sonraki Rapor Eki 22, 2026
DönemRaporEPS GerçekEPS TahminSürpriz
30 Haziran 2026 Tem 23, 2026 $7.62 $7.54 1.0%
31 Mart 2026 $7.15 $7.21 -0.85%
31 Aralık 2025 $8.14 $7.53 8.0%
30 Eylül 2025 $6.96 $5.77 20.6%
30 Haziran 2025 $6.83 $6.31 8.2%
31 Mart 2025 $6.45 $5.84 10.5%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15
Gelir Tablosu 12
Metrik Eğilim 2025202420232022202120202019201820172016
Revenue $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
SG&A Expense $548M$421M$353M$307M$337M$416M$370M$344M$340M$343M
Operating Expenses $65.77B$62.08B$57.26B$51.65B$48.92B$46.10B$46.09B$41.34B$39.23B$36.68B
Interest Expense $2.25B$2.06B$1.94B$1.74B$1.57B$1.58B$1.82B$1.75B$1.69B$1.71B
Pretax Income $9.83B$8.52B$7.71B$8.58B$9.83B$5.43B$5.24B$5.33B$4.38B$4.81B
Income Tax $2.05B$1.87B$1.61B$1.75B$2.11B$1.04B$1.10B$946M$1.64B$1.38B
Net Income $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
EPS (Basic) $28.70$22.27$19.25$19.43$21.52$11.10$10.27$10.90$6.12$7.53
EPS (Diluted) $28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
Shares (Basic) 236,413,000258,603,000272,404,000290,348,000323,315,000338,274,000341,210,000347,297,000362,305,000383,591,000
Shares (Diluted) 239,495,000261,806,000276,412,000294,666,000328,752,000343,605,000348,226,000355,303,000372,221,000395,851,000
EBITDA $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Bilanço 22
Metrik Eğilim 2025202420232022202120202019201820172016
Cash & Equivalents $1.04B$1.93B$935M$908M$1.45B$1.79B$621M$502M$732M$646M
Short-term Investments ·····$116M$147M$47M$54M$49M
Receivables $10.87B$10.75B$9.96B$8.89B$8.10B$7.05B$7.38B$6.79B$6.50B$5.83B
Inventory $1.65B$1.74B$2.02B$2.07B$1.99B$2.02B$1.85B$1.73B$1.57B$1.50B
Other Current Assets $2.22B$1.99B$2.01B$1.78B$2.01B$1.46B$1.35B$1.19B$1.17B$1.11B
Current Assets $15.78B$16.41B$14.93B$13.64B$13.54B$12.33B$11.20B$10.21B$9.98B$9.09B
PP&E (Net) $31.14B$29.41B$27.71B$25.57B$24.06B$23.20B$22.71B$19.76B$17.89B$16.35B
PP&E (Gross) $66.28B$62.51B$58.55B$54.76B$51.35B$49.32B$47.23B$42.97B$40.08B$37.05B
Accum. Depreciation $35.13B$33.10B$30.83B$29.18B$27.29B$26.12B$24.52B$23.21B$22.19B$20.70B
Other Non-current Assets $255M$230M$184M$298M$598M$546M$480M$690M$710M$1.07B
Total Assets $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Accounts Payable $4.66B$4.28B$4.23B$4.24B$4.11B$3.54B$2.90B$2.58B$2.61B$2.32B
Current Liabilities $16.35B$15.18B$12.65B$9.90B$9.58B$8.70B$7.76B$7.57B$6.16B$5.83B
Capital Leases $1.85B$1.86B$1.90B$1.75B$1.75B$1.67B$1.50B···
Total Liabilities ······$45.62B$42.12B$41.59B$39.39B
Long-term Debt $44.28B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Total Debt $41.60B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Retained Earnings $-5.72B$-2.12B$-1.35B$-2.28B$-532M$777M$-2.35B$-4.57B$-6.53B$-6.97B
AOCI $-305M$-387M$-425M$-490M$-404M$-502M$-460M$-381M$-278M$-338M
Stockholders' Equity $-6.03B$-2.50B$-1.77B$-2.77B$-933M$572M$-2.81B$-4.95B$-6.81B$-7.30B
Liabilities + Equity $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Shares Outstanding 224,605,100249,981,400265,537,300277,378,300305,476,800339,425,600338,445,600342,895,200350,091,600370,535,900
Nakit Akışı 17
Metrik Eğilim 2025202420232022202120202019201820172016
D&A $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Stock-based Comp $401M$360M$262M$341M$440M$362M$347M$268M$270M$251M
Amort. of Intangibles $12M$16M$20M$44M$25M$26M····
Other Non-cash $1.93B$1.08B$850M$-431M$-1.29B$2.40B$1.07B$461M$-3.53B$-2.67B
Operating Cash Flow $12.64B$10.51B$9.43B$8.52B$8.96B$9.23B$7.60B$6.76B$5.43B$5.65B
CapEx $4.94B$4.88B$4.74B$4.39B$3.58B$2.83B$4.16B$3.57B$3.02B$2.76B
Investing Cash Flow $-4.99B$-4.93B$-5.32B$-3.39B$-2.64B$-3.39B$-5.72B$-3.90B$-4.28B$-3.24B
Debt Issued $8.47B$7.50B$3.22B$6.00B$4.34B$2.70B$6.45B$2.00B$1.50B$5.40B
Net Debt Issued $1.08B$5.08B$2.31B$3.17B$475M$-737M$1.13B$296M$749M$925M
Stock Repurchased $10.07B$6.04B$3.81B$7.00B$8.21B$441M$1.03B$1.53B$2.05B$2.75B
Net Stock Activity $-10.07B$-6.04B$-3.81B$-7.00B$-8.21B$-441M$-1.03B$-1.53B$-2.05B$-2.75B
Dividends Paid $679M$690M$661M$653M$624M$153M$550M$487M$0·
Financing Cash Flow $-8.55B$-4.58B$-4.09B$-5.66B$-6.66B$-4.68B$-1.77B$-3.08B$-1.06B$-2.51B
Net Change in Cash $-893M$998M$27M$-543M$-342M$1.17B$119M$-230M$86M$-95M
Taxes Paid $1.74B$1.84B$1.39B$1.18B$2.18B$1.00B$849M$872M$1.21B$1.25B
Free Cash Flow $7.69B$5.64B$4.69B$4.13B$5.38B$6.40B$3.44B$3.19B$2.41B$2.89B
Levered FCF $5.91B$4.03B$3.16B$2.74B$4.15B$5.12B$2.00B$1.74B$1.35B$1.68B
Kârlılık 5
Metrik Eğilim 2025202420232022202120202019201820172016
Net Margin 9.0%8.2%8.1%9.4%11.8%7.3%6.8%8.1%··
Pretax Margin 13.0%12.1%11.9%14.2%16.7%10.5%10.2%11.4%··
EBITDA Margin 4.7%4.7%4.7%4.9%4.9%5.3%5.1%4.9%··
ROA 11.3%10.0%9.7%10.9%14.2%8.1%8.3%10.0%6.3%8.7%
ROE -159.1%-269.6%-230.9%-305.0%-3853.7%-335.8%-90.4%-64.4%-31.4%-38.8%
Likidite ve Solventlik 4
Metrik Eğilim 2025202420232022202120202019201820172016
Current Ratio 1.01.11.21.41.41.41.41.31.61.6
Quick Ratio 0.70.80.91.01.01.01.11.01.21.1
Debt / Equity -6.9-17.2-22.3-13.8-37.154.2-12.0-6.6-4.9-4.3
LT Debt / Equity -6.9-15.3-21.0-13.6-36.853.8-12.0-6.5-4.8-4.3
Verimlilik 2
Metrik Eğilim 2025202420232022202120202019201820172016
Asset Turnover 1.31.21.21.21.21.11.21.2··
Receivables Turnover 7.06.86.97.17.87.17.27.0··
Hisse Başına 6
Metrik Eğilim 2025202420232022202120202019201820172016
Book Value / Share $-26.83$-10.00$-6.68$-9.98$-3.05$1.69$-8.30$-14.44$-19.44$-19.71
Revenue / Share $315.66$269.68$235.04$204.41$178.71$149.98$147.42$131.37··
Cash Flow / Share $52.76$40.16$34.12$28.92$27.25$26.87$21.83$19.03$14.58$14.28
Cash / Share $4.63$7.73$3.52$3.27$4.75$5.28$1.83$1.46$2.09$1.74
Dividend / Share $2.88$2.64$2.40$2.24$1.92$0.43$1.60$1.40··
EPS (TTM) $28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
Büyüme Oranları 10
Metrik Eğilim 2025202420232022202120202019201820172016
Revenue YoY 7.1%8.7%7.9%2.5%14.0%·····
Revenue CAGR 3Y 7.9%6.3%8.0%·······
Revenue CAGR 5Y 8.0%·········
EPS YoY 28.8%16.0%-0.94%-9.5%93.6%·····
EPS CAGR 3Y 13.9%1.3%20.2%·······
EPS CAGR 5Y 21.0%·········
Net Income YoY 17.8%9.9%-7.1%-18.9%85.3%·····
Net Income CAGR 3Y 6.3%-6.1%11.8%·······
Net Income CAGR 5Y 12.6%·········
Dividends Paid CAGR 5Y 34.7%·········
Değerleme (TTM) 17
Metrik Eğilim 2025202420232022202120202019201820172016
Revenue TTM $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
Net Income TTM $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
Market Cap $104.86B$75.03B$71.88B$66.56B$78.48B$55.82B$50.03B$42.67B$30.75B$27.43B
Enterprise Value $145.42B$116.13B$110.53B$103.74B$111.61B$84.92B$82.98B$74.95B$63.02B$58.11B
P/E 16.513.614.312.512.115.014.711.714.810.1
P/S 1.41.11.11.11.31.11.00.90.70.7
P/B -17.4-30.0-40.5-24.1-84.197.6-17.8-8.6-4.5-3.8
P / Tangible Book ·····97.6····
P / Cash Flow 8.37.17.67.88.86.06.66.35.74.9
P / FCF 13.613.315.316.114.68.714.513.412.89.5
EV / EBITDA 41.335.135.934.939.131.232.032.929.629.6
EV / FCF 18.920.623.625.120.713.324.123.526.120.1
EV / Revenue 1.91.61.71.71.91.61.61.61.41.4
Dividend Yield 0.65%0.92%0.92%0.98%0.80%0.27%1.1%1.1%0.00%·
Earnings Yield 6.1%7.3%7.0%8.0%8.2%6.7%6.8%8.6%6.8%9.9%
Payout Ratio 10.0%12.0%12.6%11.6%9.0%4.1%15.7%12.9%··
Annual Payout $679M$690M$661M$653M$624M$153M$550M$487M$0·

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16
Metrik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Gelir $75.60B $70.60B $64.97B $60.23B $58.75B
Net Gelir $6.78B $5.76B $5.24B $5.64B $6.96B
Seyreltilmiş Hisse Başı Kâr $28.33 $22.00 $18.97 $19.15 $21.16

Kurumsal Sahipler (13F) 1.473 dosya · $57.3B toplam · Tarih itibarıyla 30 Eylül 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 1.473
Tutulan Değer $57.3B
Yeni pozisyonlar 121
Çıkan pozisyonlar 176
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
Yeni pozisyonlar Çıkan pozisyonlar Artırıldı Azaldı Net hisse senedi değişimi
121 (-64 önceki Ç'ye göre) 176 (+72 önceki Ç'ye göre) 458 (-25 önceki Ç'ye göre) 581 (+4 önceki Ç'ye göre) -627K

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum Değer Hisse senetleri % izlenen 13F'nin Tür
VANGUARD GROUP INC $6.870.392.526 14.716.173 12,00% Hisse senetleri
BlackRock, Inc. $5.069.973.824 13.003.600 8,85% Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC $3.954.150.533 10.141.708 6,91% Hisse senetleri
Sanders Capital, LLC $3.442.060.818 8.828.287 6,01% Hisse senetleri
STATE STREET CORP $2.912.102.056 7.469.035 5,09% Hisse senetleri
WELLINGTON MANAGEMENT GROUP LLP $1.835.396.649 4.707.473 3,21% Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC $1.423.654.808 3.668.008 2,49% Hisse senetleri
First Eagle Investment Management, LLC $1.284.907.912 3.295.565 2,24% Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC $1.057.704.509 2.712.828 1,85% Hisse senetleri
MORGAN STANLEY $1.008.556.857 2.586.771 1,76% Hisse senetleri
GOLDMAN SACHS GROUP INC $960.811.481 2.464.314 1,68% Hisse senetleri
JPMORGAN CHASE & CO $896.800.955 2.285.832 1,57% Hisse senetleri
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861.456.107 2.209.485 1,50% Hisse senetleri
NORGES BANK $836.457.140 2.145.367 1,46% Hisse senetleri
Capital World Investors $770.864.224 1.977.121 1,35% Hisse senetleri
Capital International Investors $747.403.041 1.916.947 1,31% Hisse senetleri
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $709.859.997 1.500.000 1,24% Hisse senetleri
NORTHERN TRUST CORP $666.150.458 1.708.560 1,16% Hisse senetleri
FMR LLC $636.503.475 1.632.520 1,11% Hisse senetleri
Invesco Ltd. $596.390.232 1.529.637 1,04% Hisse senetleri
NORDEA INVESTMENT MANAGEMENT AB $553.702.529 1.429.943 0,97% Hisse senetleri
BARCLAYS PLC $514.349.127 1.319.216 0,90% Hisse senetleri
JANUS HENDERSON GROUP PLC $481.486.890 1.017.441 0,84% Hisse senetleri
Crake Asset Management LLP $449.072.183 1.151.792 0,78% Hisse senetleri
Metropolis Capital Ltd $430.915.307 910.564 0,75% Hisse senetleri
Darsana Capital Partners LP $428.879.000 1.100.000 0,75% Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414.565.358 1.063.288 0,72% Hisse senetleri
Legal & General Group Plc $410.992.402 1.054.124 0,72% Hisse senetleri
FRANKLIN RESOURCES INC $399.958.688 1.025.824 0,70% Hisse senetleri
Life Cycle Investment Partners Ltd $355.737.196 912.404 0,62% Hisse senetleri
Bank of New York Mellon Corp $350.359.895 898.612 0,61% Hisse senetleri
VANGUARD FIDUCIARY TRUST CO $339.685.814 871.235 0,59% Hisse senetleri
ROYAL BANK OF CANADA $320.194.000 821.241 0,56% Hisse senetleri
LYRICAL ASSET MANAGEMENT LP $255.015.742 654.071 0,45% Hisse senetleri
BANK OF AMERICA CORP /DE/ $238.456.934 611.601 0,42% Hisse senetleri
SCHRODER INVESTMENT MANAGEMENT GROUP $237.236.367 608.470 0,41% Hisse senetleri
ROYAL LONDON ASSET MANAGEMENT LTD $235.649.908 604.401 0,41% Hisse senetleri
PRINCIPAL FINANCIAL GROUP INC $234.827.401 602.290 0,41% Hisse senetleri
UBS Group AG $230.953.291 592.355 0,40% Hisse senetleri
National Pension Service $230.650.346 591.578 0,40% Hisse senetleri
Russell Investments Group, Ltd. $206.832.565 530.340 0,36% Hisse senetleri
Nuveen, LLC $199.595.109 511.927 0,35% Hisse senetleri
Gobi Capital LLC $195.742.325 502.045 0,34% Hisse senetleri
Cryder Capital Partners LLP $194.561.738 499.017 0,34% Hisse senetleri
Allianz Asset Management GmbH $181.127.299 464.560 0,32% Hisse senetleri
DEUTSCHE BANK AG\ $175.985.429 451.372 0,31% Hisse senetleri
Swiss National Bank $172.097.446 441.400 0,30% Hisse senetleri
DIMENSIONAL FUND ADVISORS LP $172.079.393 441.313 0,30% Hisse senetleri
AustralianSuper Pty Ltd $159.635.782 409.438 0,28% Hisse senetleri
HSBC HOLDINGS PLC $158.555.065 406.750 0,28% Hisse senetleri

Tüm 1.473 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 4 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi Dosyalandı Hisse Durum Amaç Başvuru
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 10 Şubat 2026 31,60% İlk başvuru · SEC
22 Kasım 2006 · İlk başvuru · SEC
Merrill Lynch Bank USA 11 Eylül 2006 · İlk başvuru · SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 04 Ağustos 2006 · İlk başvuru · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 92 içeriden öğrenenler · 54 yöneticiler · 31 yönetim kurulu üyeleri

19
İçeriden Öğrenen Rol Son işlem Sahip olunan hisse senetleri Alımlar 12ay Satışlar 12ay Net 12ay
Samuel N Hazen CEO 10 Şubat 2026 F 64.842 0 7 $-21.483.290
O'Boyle Michael P President & CEO - Parallon 26 Şubat 2013 A 21.429 0 0 $0
Mike A Marks EVP and CFO 07 Mayıs 2026 G 46.576 0 0 $0
Bill B Rutherford CFO and EVP 16 Şubat 2024 F 22.251 0 0 $0
Russell K Harms CFO - Central Group 17 Kasım 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 17 Kasım 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 17 Kasım 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 01 Temmuz 2005 F 13.865 0 0 $0
Erol R Akdamar Group President 12 Kasım 2024 M 6.843 0 0 $0
Timothy M Mcmanus Group President 31 Temmuz 2024 M 27.008 0 0 $0
Richard A Hammett Group President 16 Şubat 2024 F 17.936 0 0 $0
Charles J Hall Group President 11 Kasım 2022 M 202.443 0 0 $0
Bruce A Moore JR Group President - Service Line 11 Kasım 2022 S 30.807 0 0 $0
Paul W Rutledge Group President 31 Aralık 2012 A 335.657 0 0 $0
Beverly B Wallace President - Parallon 02 Kasım 2011 M 144.714 0 0 $0
Charles Robert Evans President - Eastern Group 26 Temmuz 2006 A 62.173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 27 Ekim 2005 A 26.154 0 0 $0
Greg Roth President-Ambulatory Surgery 31 Ekim 2004 D 9.029 0 0 $0
Jay Grinney President-Eastern Group 07 Mayıs 2004 D 24.177 0 0 $0
Jon M Foster EVP and COO 10 Şubat 2026 F 23.062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 26 Ağustos 2026 J 0 0 2 $-2.747.520
Jennifer Berres SVP & Chief Human Res. Officer 11 Şubat 2026 S 11.993 0 2 $-4.126.932
Christopher F. Wyatt SVP & Controller 11 Şubat 2026 S 44.379 0 1 $-2.020.000
Erica Rossitto SVP & Chief Nurse Executive 10 Şubat 2026 F 10.407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 10 Şubat 2026 F 32.080 0 1 $-747.135
Sammie S Mosier SVP & Chief Nurse Executive 13 Şubat 2025 F 11.113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 14 Kasım 2024 S 9.454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 12 Kasım 2024 M 52.702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 05 Ağustos 2024 G 18.526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 29 Temmuz 2024 S 3.510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 25 Temmuz 2024 S 17.755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 09 Mayıs 2024 S 5.185 0 0 $0
Chad J Wasserman SVP and CIO 18 Mart 2024 M 1.576 0 0 $0
Martin P. Paslick SVP and CIO 12 Nisan 2023 M 24.643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 09 Kasım 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 05 Mayıs 2021 S 50.062 0 0 $0
William J Morrow SVP - Finance and Treasurer 18 Şubat 2021 F 5.578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 18 Şubat 2021 F 10.122 0 0 $0
Victor L Campbell SVP-Government Affairs 01 Mayıs 2019 A 194.145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 25 Şubat 2019 M 84.157 0 0 $0
Milton R Johnson Chairman 25 Şubat 2019 M 881.823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 25 Şubat 2018 M 7.003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 25 Şubat 2018 M 35.546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 25 Şubat 2018 M 65.199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 23 Mayıs 2017 M 26.378 0 0 $0
David Gwin Anderson SVP - Finance 07 Kasım 2016 M 110.167 0 0 $0
Donald W Stinnett SVP & Controller 25 Şubat 2016 A 51.965 0 0 $0
Noel B Williams SVP and CIO 16 Mayıs 2012 M 299.030 0 0 $0
Jack O Bovender JR Chairman 06 Ekim 2009 A 188.340 0 0 $0
Carl V George SVP - Development 27 Şubat 2009 M 13.092 0 0 $0
Patricia T Lindler SVP - Government Programs 17 Kasım 2006 D 0 0 0 $0
Rosalyn S Elton SVP-Operations Finance 17 Kasım 2006 D 0 0 0 $0
Frank M Houser MD SVP-Quality & Medical Director 26 Temmuz 2006 A 46.145 0 0 $0
James A Fitzgerald JR SVP-Supply Chain Operations 29 Ocak 2006 F 20.674 0 0 $0
Andrea B Smith Yönetim kurulu üyesi 28 Nisan 2026 A 4.666 0 0 $0
William R Frist Yönetim kurulu üyesi 28 Nisan 2026 A 13.740 0 0 $0
Wayne Joseph Riley Yönetim kurulu üyesi 28 Nisan 2026 A 15.029 0 0 $0
Hugh F Johnston Yönetim kurulu üyesi 28 Nisan 2026 A 4.475 0 0 $0
Thomas F Frist III Yönetim kurulu üyesi 28 Nisan 2026 A 15.858 0 0 $0
Michael W Michelson Yönetim kurulu üyesi 28 Nisan 2026 A 12.576 0 0 $0
Nancy Ann Deparle Yönetim kurulu üyesi 28 Nisan 2026 A 21.910 0 0 $0
John Chidsey Yönetim kurulu üyesi 28 Nisan 2026 A 1.305 0 0 $0
Robert J Dennis Yönetim kurulu üyesi 29 Nisan 2025 A 26.601 0 0 $0
Meg Crofton Yönetim kurulu üyesi 29 Nisan 2024 A 6.331 0 0 $0
Charles O Holliday JR Yönetim kurulu üyesi 25 Nisan 2022 A 18.955 0 0 $0
Geoffrey G Meyers Yönetim kurulu üyesi 01 Mayıs 2019 A 39.153 0 0 $0
John W Rowe Yönetim kurulu üyesi 01 Mayıs 2019 A 30.388 0 0 $0
Ann H Lamont Yönetim kurulu üyesi 02 Mayıs 2018 A 17.661 0 0 $0
Jay O Light Yönetim kurulu üyesi 03 Mayıs 2017 A 30.953 0 0 $0
Stephen G Pagliuca Yönetim kurulu üyesi 05 Aralık 2014 D 7.612.921 0 0 $0
Christopher R Gordon Yönetim kurulu üyesi 01 Kasım 2013 D 30.003.156 0 0 $0
John Connaughton Yönetim kurulu üyesi 01 Kasım 2013 D 30.003.156 0 0 $0
John H Mcarthur Yönetim kurulu üyesi 17 Kasım 2006 D 0 0 0 $0
Kent C Nelson Yönetim kurulu üyesi 17 Kasım 2006 D 0 0 0 $0
Magdalena Averhoff MD Yönetim kurulu üyesi 17 Kasım 2006 D 0 0 0 $0
Glenda A Hatchett Yönetim kurulu üyesi 17 Kasım 2006 D 0 0 0 $0
Frederick W Gluck Yönetim kurulu üyesi 17 Kasım 2006 D 0 0 0 $0
Harold T Shapiro Yönetim kurulu üyesi 17 Kasım 2006 D 0 0 0 $0
Michael C Armstrong Yönetim kurulu üyesi 17 Kasım 2006 D 0 0 0 $0
Martin Feldstein Yönetim kurulu üyesi 17 Kasım 2006 D 0 0 0 $0
Michael T Long Yönetim kurulu üyesi 17 Kasım 2006 D 0 0 0 $0
ROYAL FRANK S Yönetim kurulu üyesi 17 Kasım 2006 D 0 0 0 $0
Patricia F Elcan 10% sahip 06 Şubat 2026 J 36.557.141 0 0 $0
Frisco Holding II 10% sahip 06 Şubat 2026 J 36.557.141 0 0 $0
HERCULES HOLDING II, LLC 10% sahip 06 Şubat 2026 J 32.282.889 0 0 $0
Thomas F Frist JR 10% sahip 06 Şubat 2026 J 36.557.141 0 0 $0
Patricia C Frist 10% sahip 20 Şubat 2018 G 0 0 0 $0
KKR PEI GP LTD 10% sahip 01 Nisan 2014 J 0 0 0 $0
Jonathan B Perlin · 02 Ağustos 2021 S 44.348 0 0 $0
Juan Vallarino · 09 Mayıs 2016 M 61.036 0 0 $0
Richard M Bracken · 31 Aralık 2014 F 82.499 0 0 $0
BANK OF AMERICA CORP /DE/ · 06 Kasım 2012 S 2.652.364 0 0 $0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 141 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon Ağırlık Birimler Tarih itibarıyla Kaynak
BUL · Pacer Funds Trust 5,07% 16.545 NS 31 Temmuz 2026 N-PORT
IHF · iShares Trust 4,75% 147.977 SH 11 Eylül 2026 Günlük
STNC · Hennessy Funds Trust 3,17% 7.315 NS 31 Temmuz 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2,50% 97.403 SH 01 Ekim 2026 Günlük
COWZ · Pacer Funds Trust 2,07% 960.711 NS 31 Temmuz 2026 N-PORT
WLTG · ETF Opportunities Trust 2,06% 3.942 NS 31 Temmuz 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,65% 33.803 SH 01 Ekim 2026 Günlük
RPG · Invesco Exchange-Traded Fund Trust 1,30% 58.562 SH 01 Ekim 2026 Günlük
FLAG · Global X Funds 1,14% 48 NS 31 Temmuz 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1,03% 6.909 NS 31 Temmuz 2026 N-PORT
IYH · iShares Trust 1,01% 87.417 SH 11 Eylül 2026 Günlük
SRHQ · Elevation Series Trust 0,94% 4.938 NS 31 Temmuz 2026 N-PORT
NEAR · iShares U.S. ETF Trust 0,92% 48.109.000 SH 11 Eylül 2026 Günlük
FHLC · FIDELITY COVINGTON TRUST 0,91% 74.445 NS 31 Temmuz 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,90% 470.451 SH 19 Ağustos 2026 Günlük
FXH · First Trust Exchange-Traded AlphaDE… 0,87% 22.725 NS 31 Temmuz 2026 N-PORT
DIVB · iShares Trust 0,87% 42.100 SH 11 Eylül 2026 Günlük
NFRA · FlexShares Trust 0,84% 62.628 NS 31 Temmuz 2026 N-PORT
IXJ · iShares Trust 0,83% 81.708 SH 11 Eylül 2026 Günlük
SPVM · Invesco Exchange-Traded Fund Trust 0,81% 2.483 SH 01 Ekim 2026 Günlük
QUVU · Hartford Funds Exchange-Traded Trust 0,79% 3.522 NS 31 Temmuz 2026 N-PORT
BSCT · Invesco Exchange-Traded Self-Indexe… 0,78% 23.458.000 01 Ekim 2026 Günlük
BSCS · Invesco Exchange-Traded Self-Indexe… 0,74% 25.897.000 01 Ekim 2026 Günlük
CURE · Direxion Shares ETF Trust 0,72% 3.056 NS 31 Temmuz 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,67% 12.075 SH 19 Ağustos 2026 Günlük
LGDX · Tidal Trust III 0,66% 2.345 NS 31 Temmuz 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,55% 11.876 SH 19 Ağustos 2026 Günlük
BSCR · Invesco Exchange-Traded Self-Indexe… 0,50% 22.893.000 01 Ekim 2026 Günlük
LSVD · ADVISORS' INNER CIRCLE FUND 0,46% 7.404 NS 31 Temmuz 2026 N-PORT
WLDR · Two Roads Shared Trust 0,43% 964 NS 31 Temmuz 2026 N-PORT
ROUS · Lattice Strategies Trust 0,42% 7.289 NS 31 Temmuz 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0,41% 92.254 SH 01 Ekim 2026 Günlük
QLC · FlexShares Trust 0,39% 9.856 NS 31 Temmuz 2026 N-PORT
XOEF · iShares Trust 0,37% 194 SH 11 Eylül 2026 Günlük
GSY · Invesco Actively Managed Exchange-T… 0,36% 14.000.000 01 Ekim 2026 Günlük
UPSD · ETF Series Solutions 0,33% 972 NS 31 Temmuz 2026 N-PORT
BSCU · Invesco Exchange-Traded Self-Indexe… 0,33% 9.324.000 01 Ekim 2026 Günlük
MGV · VANGUARD WORLD FUND 0,29% 97.604 SH 19 Ağustos 2026 Günlük
PFIG · Invesco Exchange-Traded Fund Trust … 0,28% 390.000 01 Ekim 2026 Günlük
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,28% 3.186 NS 31 Temmuz 2026 N-PORT
USXF · iShares Trust 0,26% 9.226 SH 11 Eylül 2026 Günlük
IUS · Invesco Exchange-Traded Self-Indexe… 0,26% 5.803 SH 01 Ekim 2026 Günlük
IWX · iShares Trust 0,23% 21.535 SH 11 Eylül 2026 Günlük
VTV · VANGUARD INDEX FUNDS 0,23% 1.475.731 SH 19 Ağustos 2026 Günlük
JMOM · J.P. Morgan Exchange-Traded Fund Tr… 0,23% 14.235 NS 31 Temmuz 2026 N-PORT
MPLY · Strategy Shares 0,22% 87 NS 31 Temmuz 2026 N-PORT
EUSA · iShares, Inc. 0,21% 9.589 SH 11 Eylül 2026 Günlük
RSP · Invesco Exchange-Traded Fund Trust 0,21% 463.744 SH 01 Ekim 2026 Günlük
FTC · First Trust Exchange-Traded AlphaDE… 0,20% 6.420 NS 31 Temmuz 2026 N-PORT
SIZE · iShares Trust 0,19% 1.920 SH 11 Eylül 2026 Günlük
DYNF · BlackRock ETF Trust 0,19% 183.934 SH 11 Eylül 2026 Günlük
VMAX · Lattice Strategies Trust 0,19% 228 NS 31 Temmuz 2026 N-PORT
DSI · iShares Trust 0,19% 23.734 SH 11 Eylül 2026 Günlük
ILCV · iShares Trust 0,18% 5.870 SH 10 Eylül 2026 Günlük
IVW · iShares Trust 0,18% 331.185 SH 11 Eylül 2026 Günlük
IUSG · iShares Trust 0,17% 136.713 SH 11 Eylül 2026 Günlük
VOOG · VANGUARD ADMIRAL FUNDS 0,17% 115.334 SH 19 Ağustos 2026 Günlük
IWD · iShares Trust 0,17% 332.035 SH 11 Eylül 2026 Günlük
OMFL · Invesco Exchange-Traded Self-Indexe… 0,16% 17.845 SH 01 Ekim 2026 Günlük
VONV · VANGUARD SCOTTSDALE FUNDS 0,16% 90.157 SH 19 Ağustos 2026 Günlük
USMV · iShares Trust 0,16% 89.855 SH 11 Eylül 2026 Günlük
ACWV · iShares, Inc. 0,15% 11.903 SH 11 Eylül 2026 Günlük
EGLE · Global X Funds 0,15% 8 NS 31 Temmuz 2026 N-PORT
GLBL · Pacer Funds Trust 0,15% 4 NS 31 Temmuz 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,15% 33.327 SH 01 Ekim 2026 Günlük
VOXP · Advisors Series Trust 0,13% 18 NS 31 Temmuz 2026 N-PORT
VRIG · Invesco Actively Managed Exchange-T… 0,12% 2.250.000 01 Ekim 2026 Günlük
TOPC · iShares Trust 0,12% 95 SH 11 Eylül 2026 Günlük
DGRO · iShares Trust 0,12% 120.741 SH 11 Eylül 2026 Günlük
QVML · Invesco Exchange-Traded Fund Trust … 0,11% 4.392 SH 01 Ekim 2026 Günlük
XVV · iShares Trust 0,11% 1.790 SH 11 Eylül 2026 Günlük
IWL · iShares Trust 0,11% 5.786 SH 11 Eylül 2026 Günlük
MGC · VANGUARD WORLD FUND 0,11% 31.176 SH 19 Ağustos 2026 Günlük
ACIO · ETF Series Solutions 0,11% 6.205 NS 31 Temmuz 2026 N-PORT
EVUS · iShares Trust 0,10% 934 SH 11 Eylül 2026 Günlük
ADME · ETF Series Solutions 0,10% 751 NS 31 Temmuz 2026 N-PORT
XRMI · Global X Funds 0,10% 126 NS 31 Temmuz 2026 N-PORT
XCLR · Global X Funds 0,10% 9 NS 31 Temmuz 2026 N-PORT
XYLD · Global X Funds 0,10% 8.148 NS 31 Temmuz 2026 N-PORT
XTR · Global X Funds 0,10% 12 NS 31 Temmuz 2026 N-PORT
PBUS · Invesco Exchange-Traded Fund Trust … 0,10% 26.763 SH 01 Ekim 2026 Günlük
BKLC · BNY Mellon ETF Trust 0,10% 13.621 NS 31 Temmuz 2026 N-PORT
VV · VANGUARD INDEX FUNDS 0,10% 181.364 SH 19 Ağustos 2026 Günlük
ESGV · VANGUARD WORLD FUND 0,10% 33.758 SH 19 Ağustos 2026 Günlük
IVV · iShares Trust 0,10% 1.957.485 SH 11 Eylül 2026 Günlük
PTLC · Pacer Funds Trust 0,10% 7.919 NS 31 Temmuz 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,10% 1.395 NS 31 Temmuz 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0,10% 877 SH 01 Ekim 2026 Günlük
EQAL · Invesco Exchange-Traded Fund Trust … 0,10% 1.791 SH 01 Ekim 2026 Günlük
ILCB · iShares Trust 0,10% 2.915 SH 11 Eylül 2026 Günlük
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0,09% 20.766 NS 31 Temmuz 2026 N-PORT
IYY · iShares Trust 0,09% 6.693 SH 11 Eylül 2026 Günlük
VOTE · TCW ETF Trust 0,09% 2.545 NS 31 Temmuz 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,09% 3.614 NS 31 Temmuz 2026 N-PORT
XYLG · Global X Funds 0,09% 147 NS 31 Temmuz 2026 N-PORT
DFUS · Dimensional ETF Trust 0,09% 46.791 NS 31 Temmuz 2026 N-PORT
IWB · iShares Trust 0,09% 103.721 SH 11 Eylül 2026 Günlük
VOO · VANGUARD INDEX FUNDS 0,09% 4.034.357 SH 19 Ağustos 2026 Günlük
TOV · EA Series Trust 0,09% 607 NS 31 Temmuz 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,09% 586 NS 31 Temmuz 2026 N-PORT
ITOT · iShares Trust 0,09% 202.387 SH 11 Eylül 2026 Günlük
ACVF · ETF Opportunities Trust 0,09% 337 NS 31 Temmuz 2026 N-PORT
GTOS · Invesco Actively Managed Exchange-T… 0,09% 104.000 01 Ekim 2026 Günlük
QDPL · Pacer Funds Trust 0,09% 3.708 NS 31 Temmuz 2026 N-PORT
IWV · iShares Trust 0,09% 41.034 SH 11 Eylül 2026 Günlük
DFAU · Dimensional ETF Trust 0,08% 25.516 NS 31 Temmuz 2026 N-PORT
CRBN · iShares Trust 0,08% 2.269 SH 11 Eylül 2026 Günlük
PHDG · Invesco Actively Managed Exchange-T… 0,08% 116 SH 01 Ekim 2026 Günlük
TOK · iShares Trust 0,08% 451 SH 11 Eylül 2026 Günlük
VTI · VANGUARD INDEX FUNDS 0,08% 4.930.930 SH 19 Ağustos 2026 Günlük
VONE · VANGUARD SCOTTSDALE FUNDS 0,08% 24.633 SH 19 Ağustos 2026 Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS 0,08% 12.577 SH 19 Ağustos 2026 Günlük
HCMT · Direxion Shares ETF Trust 0,08% 1.081 NS 31 Temmuz 2026 N-PORT
TILT · FlexShares Trust 0,08% 4.108 NS 31 Temmuz 2026 N-PORT
SPXL · Direxion Shares ETF Trust 0,07% 12.141 NS 31 Temmuz 2026 N-PORT
URTH · iShares, Inc. 0,07% 14.079 SH 11 Eylül 2026 Günlük
ACWI · iShares Trust 0,06% 50.294 SH 11 Eylül 2026 Günlük
HDUS · Lattice Strategies Trust 0,05% 275 NS 31 Temmuz 2026 N-PORT
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,05% 125.729 SH 19 Ağustos 2026 Günlük
DCOR · Dimensional ETF Trust 0,05% 3.816 NS 31 Temmuz 2026 N-PORT
GLOF · iShares Trust 0,04% 202 SH 11 Eylül 2026 Günlük
DUHP · Dimensional ETF Trust 0,04% 10.761 NS 31 Temmuz 2026 N-PORT
DFAC · Dimensional ETF Trust 0,02% 28.662 NS 31 Temmuz 2026 N-PORT
DFSU · Dimensional ETF Trust 0,02% 1.127 NS 31 Temmuz 2026 N-PORT
DXUV · Dimensional ETF Trust 0,01% 99 NS 31 Temmuz 2026 N-PORT
GTO · Invesco Actively Managed Exchange-T… 0,00% 42.000 30 Eylül 2026 Günlük
CBLS · Elevation Series Trust -1,12% -1.546 NS 31 Temmuz 2026 N-PORT
BIV · VANGUARD BOND INDEX FUNDS · · 15 Temmuz 2026 Günlük
BLV · VANGUARD BOND INDEX FUNDS · · 15 Temmuz 2026 Günlük
BSV · VANGUARD BOND INDEX FUNDS · · 15 Temmuz 2026 Günlük
BND · VANGUARD BOND INDEX FUNDS · · 15 Temmuz 2026 Günlük
VUSB · VANGUARD BOND INDEX FUNDS · · 15 Temmuz 2026 Günlük
VCRB · VANGUARD MALVERN FUNDS · · 15 Temmuz 2026 Günlük
VPLS · VANGUARD MALVERN FUNDS · · 15 Temmuz 2026 Günlük
VSDB · VANGUARD MALVERN FUNDS · · 15 Temmuz 2026 Günlük
VCSH · VANGUARD SCOTTSDALE FUNDS · · 15 Temmuz 2026 Günlük
VCIT · VANGUARD SCOTTSDALE FUNDS · · 15 Temmuz 2026 Günlük
VCLT · VANGUARD SCOTTSDALE FUNDS · · 15 Temmuz 2026 Günlük
VTC · VANGUARD SCOTTSDALE FUNDS · · 30 Temmuz 2026 Günlük
BNDW · VANGUARD SCOTTSDALE FUNDS · · 30 Temmuz 2026 Günlük
VCEB · VANGUARD WORLD FUND · · 30 Temmuz 2026 Günlük

HCA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21
derecelendirme · 30 analist AL
Medyan hedef $450.00 +5,5%
6 20,0% Güçlü Al
11 36,7% Al
12 40,0% Tut
1 3,3% Sat
0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

22 analist · 2026-09-28

Ortalama hedef $454.23 +6,5%

Şimdi Mevcut fiyat $426.69
Düşük$380.00 Ortalama$454.23 Yüksek$579.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü Piyasa Değeri P/E Gelir YoY Net Kar Marjı ROE Brüt Kar Marjı
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·
THC $17.28B 12.8 3.1% 11.1% 56.4% ·
EHC $10.61B 19.2 10.5% 9.5% 25.1% ·
UHS · 9.4 9.7% 8.6% 21.4% ·
ENSG $10.12B 29.8 18.7% 6.8% 16.9% ·
PACS $6.01B 31.5 29.3% 3.6% 23.1% ·
CON $2.53B 15.1 13.9% 7.7% 49.8% ·
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9% ·
SNDA $612M -7.7 25.2% -18.6% -197.2% ·

Son Haberler Bu şirketten bahseden son manşetler

23

İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri

25

Şu anda açık sinyal yok — hiçbir kart dolu değil ve bu dürüstçe.

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

Kaynak: SEC 10-Q dosyalandı Tem 28, 2026